REGISTERED NUMBER: 12653853 (England and Wales)

Gormley Healthcare Limited

Financial Statements for the Year Ended 30 June 2026

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr J Gormley

Mrs H Gormley

REGISTERED OFFICE:

4 Raby Park

Wetherby

LS22 6SA

REGISTERED NUMBER:

12653853 (England and Wales)

ACCOUNTANTS:

Wild & Co Chartered Accountants

Windsor House

Cornwall Road

Harrogate

HG1 2PW

FIXED ASSETS

Tangible assets

4

7,243

9,427

Investments

5

4,025

4,025

11,268

13,452

CURRENT ASSETS

Debtors

16,645

26,050

Cash at bank

295,558

134,364

312,203

160,414

CREDITORS

Amounts falling due within one year

63,001

29,766

NET CURRENT ASSETS

249,202

130,648

TOTAL ASSETS LESS CURRENT LIABILITIES

260,470

144,100

PROVISIONS FOR LIABILITIES

6

2,817

-

NET ASSETS

257,653

144,100

CAPITAL AND RESERVES

Called up share capital

7

100

2

Retained earnings

257,553

144,098

SHAREHOLDERS' FUNDS

257,653

144,100

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 30 June 2026 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2026 and were signed on its behalf by:

Mr J Gormley - Director

1.	STATUTORY INFORMATION

Gormley Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

Straight line over 3 years

Fixtures and fittings

-

Straight line over 3 years

Computer equipment

-

Straight line over 3 years

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investments in listed investments

Listed investments which are publicly traded are initially measured at transaction price and subsequently measured at fair value, with changes in fair value recognised in the profit and loss.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 July 2025

17,745

Additions

2,722

At 30 June 2026

20,467

DEPRECIATION

At 1 July 2025

8,318

Charge for year

4,906

At 30 June 2026

13,224

NET BOOK VALUE

At 30 June 2026

7,243

At 30 June 2025

9,427

5.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST

At 1 July 2025

and 30 June 2026

4,025

NET BOOK VALUE

At 30 June 2026

4,025

At 30 June 2025

4,025

6.	PROVISIONS FOR LIABILITIES

30.6.26

30.6.25

£

£

Deferred tax

2,817

-

Deferred

tax

£

Provided during year

2,817

Balance at 30 June 2026

2,817

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.6.26

30.6.25

value:

£

£

2

Ordinary shares

£1

-

2

100

45 A, 45 B, 10 C Ordinary

shares

£1

100

-

100

2

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 June 2026 and 30 June 2025:

30.6.26

30.6.25

£

£

Mr J Gormley and Mrs H Gormley

Balance outstanding at start of year

(42

)

15,907

Amounts advanced

(12,500

)

(18,744

)

Amounts repaid

544

2,795

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(11,998

)

(42

)

Director loan of £11,998 is money advanced to the Company by the Director as at 30 June 2026. The loan is unsecured and interest free. The loan is repayable on demand.